MannKind Corp.
(NASDAQ : MNKD)

( )
MNKD After-Hours: () as of PM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Interested in Gold Updates?
Receive the latest updates on the gold and silver markets.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
AMGNAmgen Inc.
-0.23%177.061.3%$498.32m
CELGCelgene Corporation
-0.72%90.871.3%$432.96m
GILDGilead Sciences, Inc.
-0.03%66.920.9%$402.64m
ARRYArray BioPharma Inc.
-0.24%46.268.1%$386.28m
ILMNIllumina, Inc.
0.20%302.903.5%$363.97m
BIIBBiogen Inc.
-0.91%229.441.3%$358.04m
REGNRegeneron Pharmaceuticals, Inc.
0.35%299.422.6%$269.93m
ALXNAlexion Pharmaceuticals, Inc.
0.48%123.412.0%$204.86m
SRPTSarepta Therapeutics, Inc.
0.49%154.0014.7%$185.82m
VRTXVertex Pharmaceuticals Incorporated
0.56%177.141.9%$179.41m
AAgilent Technologies, Inc.
-0.52%69.591.6%$147.34m
EXASExact Sciences Corporation
1.21%116.3424.1%$140.14m
INCYIncyte Corporation
0.44%80.232.5%$100.62m
BLUEBluebird Bio, Inc.
4.33%139.4514.3%$97.82m
SGENSeattle Genetics, Inc.
18.98%75.176.5%$93.47m

Company Profile

MannKind Corp. is a biopharmaceutical company. It focuses on the discovery, development and, commercialization of therapeutic products for diseases, such as diabetes and cancer. The company was founded by Alfred E. Mann on February 14, 1991 and is headquartered in Westlake Village, CA.